Bluejay Investor Presentation Deck

Management & Advisors: Leadership, Diagnostic & Product Launch Expertise Indranil "Neil" Dey CEO and Co-founder Involved in introducing Her2neu test for Herceptin Ph.D. in Biochemistry (UNESCO fellow) from BRC, Hungary, MBA (Fulbright Scholar) from Cambridge University, UK TM bluejay DIAGNOSTICS IMPATH The Cancer Information Company Kenneth Fisher Chief Financial Officer Responsible for finance, investor relations, accounting and administrative operations CPA; BA, Business Administration, Isenberg School of Management, University of Massachusetts at Amherst East Boston Savings Bank Jason Cook Chief Technology Officer Responsible for product development and manufacturing operations 15+ years in POC/ diagnostics product development Ph.D. in Biomedical Engineering, University of Texas at Austin D TEXAS The University of Texas at Austin Mark Feinberg Chief Medical Advisor Responsible for clinical development programs and strategic medical leadership Associate Professor, Harvard Medical School/Cardiovascular, Brigham & Women's; Medical College of Pennsylvania Brigham and Women's Hospital Founding Member, Mass General Brigham Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | August 2023 16

View entire presentation